Myeloid-derived suppressor cells participate in preventing graft rejection

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Wang, Yan ^a   Gu, Xiaodong ^a   Xiang, Jianbin ^a   Chen, Zongyou ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; BIOLOGICAL MARKER;

AUTOIMMUNITY; BONE MARROW CELL; BREAST CARCINOMA; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL POPULATION; COLON CARCINOMA; GRAFT REJECTION; HEART GRAFT; HELPER CELL; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFECTION; KIDNEY ALLOGRAFT; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LIVER GRAFT; LUNG NON SMALL CELL CANCER; LYMPHOCYTE FUNCTION; MELANOMA; MYELODYSPLASTIC SYNDROME; MYELOID DERIVED SUPPRESSOR CELL; NONHODGKIN LYMPHOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; REGULATORY T LYMPHOCYTE; REVIEW; SKIN ALLOGRAFT; T LYMPHOCYTE; TRANSPLANTATION; TUMOR GROWTH; ADOPTIVE TRANSFER; ALLOTRANSPLANTATION; ANIMAL; ANTIGEN PRESENTATION; CYTOLOGY; GRANULOCYTE; IMMUNOLOGY; MONOCYTE; MOUSE; ORGAN TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; GRAFT REJECTION; GRANULOCYTES; HUMANS; IMMUNE TOLERANCE; MICE; MONOCYTES; MYELOID CELLS; ORGAN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84859727200     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/731486     Document Type: Review

References (57)

1. Young M. R., Newby M., Wepsic H. T., Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors Cancer Research 1987 47 1 100 105 (Pubitemid 17002105)
2. Pastua A., Marcinkiewicz J., Myeloid-derived suppressor cells: a double-edged sword? International Journal of Experimental Pathology 2011 92 2 73 78
3. Ribechini E., Greifenberg V., Sandwick S., Lutz M. B., Subsets, expansion and activation of myeloid-derived suppressor cells Medical Microbiology and Immunology 2010 199 3 273 281
4. Gabrilovich D. I., Nagaraj S., Myeloid-derived suppressor cells as regulators of the immune system Nature Reviews Immunology 2009 9 3 162 174
5. Buessow S. C., Paul R. D., Lopez D. M., Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice Journal of the National Cancer Institute 1984 73 1 249 255 (Pubitemid 14090853)
6. Ostrand-Rosenberg S., Sinha P., Myeloid-derived suppressor cells: linking inflammation and cancer Journal of Immunology 2009 182 8 4499 4506
7. Condamine T., Gabrilovich D. I., Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function Trends in Immunology 2011 32 1 19 25
8. Murdoch C., Muthana M., Coffelt S. B., Lewis C. E., The role of myeloid cells in the promotion of tumour angiogenesis Nature Reviews Cancer 2008 8 8 618 631
9. Kusmartsev S., Gabrilovich D. I., Immature myeloid cells and cancer-associated immune suppression Cancer Immunology, Immunotherapy 2002 51 6 293 298 (Pubitemid 34743981)
10. Serafini P., De Santo C., Marigo I., Cingarlini S., Dolcetti L., Gallina G., Zanovello P., Bronte V., Derangement of immune responses by myeloid suppressor cells Cancer Immunology, Immunotherapy 2004 53 2 64 72 (Pubitemid 38161211)
11. Bronte V., Serafini P., Apolloni E., Zanovello P., Tumor-induced immune dysfunctions caused by myeloid suppressor cells Journal of Immunotherapy 2001 24 6 431 446 (Pubitemid 33104863)
12. Baniyash M., TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response Nature Reviews Immunology 2004 4 9 675 687 (Pubitemid 39223074)
13. Gabrilovich D., Mechanisms and functional significance of tumour-induced dendritic-cell defects Nature Reviews Immunology 2004 4 12 941 952 (Pubitemid 39620069)
14. Garcia M. R., Ledgerwood L., Yang Y., Xu J., Lal G., Burrell B., Ma G., Hashimoto D., Li Y., Boros P., Grisotto M., Van Rooijen N., Matesanz R., Tacke F., Ginhoux F., Ding Y., Chen S. H., Randolph G., Merad M., Bromberg J. S., Ochando J. C., Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice Journal of Clinical Investigation 2010 120 7 2486 2496
15. Dugast A. S., Haudebourg T., Coulon F., Heslan M., Haspot F., Poirier N., De Silly R. V., Usal C., Smit H., Martinet B., Thebault P., Renaudin K., Vanhove B., Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector t cell expansion Journal of Immunology 2008 180 12 7898 7906
16. Rodriguez P. C., Ernstoff M. S., Hernandez C., Atkins M., Zabaleta J., Sierra R., Ochoa A. C., Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes Cancer Research 2009 69 4 1553 1560
17. Liu C.-Y., Wang Y.-M., Wang C.-L., Feng P.-H., Ko H.-W., Liu Y.-H., Wu Y.-C., Chu Y., Chung F.-T., Kuo C.-H., Lee K.-Y., Lin S.-M., Lin H.-C., Wang C.-H., Yu C.-T., Kuo H.-P., Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b + /CD14 - /CD15 + /CD33 + myeloid-derived suppressor cells and CD8 + T lymphocytes in patients with advanced-stage non-small cell lung cancer Journal of Cancer Research and Clinical Oncology 2010 136 1 35 45
18. Diaz-Montero C. M., Salem M. L., Nishimura M. I., Garrett-Mayer E., Cole D. J., Montero A. J., Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy Cancer Immunology, Immunotherapy 2009 58 1 49 59
19. Vuk-Pavlovi S., Bulur P. A., Lin Y., Qin R., Szumlanski C. L., Zhao X., Dietz A. B., Immunosuppressive CD14 + HLA-DR low/- monocytes in prostate cancer Prostate 2010 70 4 443 455
20. Filipazzi P., Valenti R., Huber V., Pilla L., Canese P., Iero M., Castelli C., Mariani L., Parmiani G., Rivoltini L., Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine Journal of Clinical Oncology 2007 25 18 2546 2553 (Pubitemid 47041228)
21. Poschke I., Mougiakakos D., Hansson J., Masucci G. V., Kiessling R., Immature immunosuppressive CD14 + HLA-DR -/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign Cancer Research 2010 70 11 4335 4345
22. Hoechst B., Ormandy L. A., Ballmaier M., Lehner F., Krger C., Manns M. P., Greten T. F., Korangy F., A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4 + CD25 + Foxp3 + T Cells Gastroenterology 2008 135 1 234 243 (Pubitemid 351899008)
23. Hoechst B., Voigtlaender T., Ormandy L., Gamrekelashvili J., Zhao F., Wedemeyer H., Lehner F., Manns M. P., Greten T. F., Korangy F., Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor Hepatology 2009 50 3 799 807
24. Parrinello N., La Cava P., Tibullo D., Myeloid-derived suppressor cells in patients with multiple myeloma and monoclonal gammopathy of undetermined significance Blood 114 22, abstract 4890
25. Lin Y., Gustafson M. P., Bulur P. A., Gastineau D. A., Witzig T. E., Dietz A. B., Immunosuppressive CD14 + HLA-DR low/- monocytes in B-cell non-Hodgkin lymphoma Blood 2011 117 3 872 881
26. Wei S., Myeloid-derived suppressor cells (MDSC) are effectors of bone marrow suppression in lower risk myelodysplastic syndromes (MDS) Blood 2009 114 22, abstract 597
27. Adeegbe D., Serafini P., Bronte V., Zoso A., Ricordi C., Inverardi L., In vivo induction of myeloid suppressor cells and CD4 + foxp3 + T regulatory cells prolongs skin allograft survival in mice Cell Transplantation 2011 20 6 941 954
28. Zhang W., Liang S., Wu J., Horuzsko A., Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b + Gr1 + myeloid-derived suppressor cells that promote long-term survival of allografts Transplantation 2008 86 8 1125 1134
29. De Wilde V., Van Rompaey N., Hill M., Lebrun J. F., Lematre P., Lhommé F., Kubjak C., Vokaer B., Oldenhove G., Charbonnier L. M., Cuturi M. C., Goldman M., Le Moine A., Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1 American Journal of Transplantation 2009 9 9 2034 2047
30. Chou H.-S., Hsieh C.-C., Yang H.-R., Wang L., Arakawa Y., Brown K., Wu Q., Lin F., Peters M., Fung J. J., Lu L., Qian S., Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice Hepatology 2011 53 3 1007 1019
31. Turnquist H. R., Zhao Z., Rosborough B. R., Liu Q., Castellaneta A., Isse K., Wang Z., Lang M., Stolz D. B., Zheng X. X., Demetris A. J., Liew F. Y., Wood K. J., Thomson A. W., IL-33 expands suppressive CD11b + Gr-1 int and regulatory T cells, including ST2L + Foxp3 + cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival Journal of Immunology 2011 187 9 4598 4610
32. Melani C., Chiodoni C., Forni G., Colombo M. P., Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity Blood 2003 102 6 2138 2145 (Pubitemid 37122391)
33. Youn J. I., Nagaraj S., Collazo M., Gabrilovich D. I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice Journal of Immunology 2008 181 8 5791 5802
34. Bronte V., Apolloni E., Cabrelle A., Ronca R., Serafini P., Zamboni P., Restifo N. P., Zanovello P., Identification of a CD11b + /Gr-1 + /CD31 + myeloid progenitor capable of activating or suppressing CD8 + T cells Blood 2000 96 12 3838 3846
35. Huang B., Pan P. Y., Li Q., Sato A. I., Levy D. E., Bromberg J., Divino C. M., Chen S. H., Gr-1 + CD115 + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host Cancer Research 2006 66 2 1123 1131 (Pubitemid 43165981)
36. Almand B., Clark J. I., Nikitina E., Van Beynen J., English N. R., Knight S. C., Carbone D. P., Gabrilovich D. I., Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer Journal of Immunology 2001 166 1 678 689 (Pubitemid 32038493)
37. Ochoa A. C., Zea A. H., Hernandez C., Rodriguez P. C., Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma Clinical Cancer Research 2007 13 2 721s 726s
38. Movahedi K., Guilliams M., Van Den Bossche J., Van Den Bergh R., Gysemans C., Beschin A., De Baetselier P., Van Ginderachter J. A., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell suppressive activity Blood 2008 111 8 4233 4244
39. Rodrguez P. C., Ochoa A. C., Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives Immunological Reviews 2008 222 1 180 191 (Pubitemid 351430370)
40. Bronte V., Serafini P., De Santo C., Marigo I., Tosello V., Mazzoni A., Segal D. M., Staib C., Lowel M., Sutter G., Colombo M. P., Zanovello P., IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice Journal of Immunology 2003 170 1 270 278 (Pubitemid 36026149)
41. Rodriguez P. C., Quiceno D. G., Ochoa A. C., L-arginine availability regulates T-lymphocyte cell-cycle progression Blood 2007 109 4 1568 1573 (Pubitemid 46239590)
42. Highfill S. L., Rodriguez P. C., Zhou Q., Goetz C. A., Koehn B. H., Veenstra R., Taylor P. A., Panoskaltsis-Mortari A., Serody J. S., Munn D. H., Tolar J., Ochoa A. C., Blazar B. R., Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13 Blood 2010 116 25 5738 5747
43. Serafini P., Borrello I., Bronte V., Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression Seminars in Cancer Biology 2006 16 1 53 65 (Pubitemid 43139709)
44. Harari O., Liao J. K., Inhibition of MHC II gene transcription by nitric oxide and antioxidants Current Pharmaceutical Design 2004 10 8 893 898 (Pubitemid 38380067)
45. Soares M. P., Lin Y., Anrather J., Csizmadia E., Takigami K., Sato K., Grey S. T., Colvin R. B., Choi A. M., Poss K. D., Bach F. H., Expression of heme oxygenase-1 can determine cardiac xenograft survival Nature Medicine 1998 4 9 1073 1077 (Pubitemid 28417343)
46. Ryter S. W., Alam J., Choi A. M. K., Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications Physiological Reviews 2006 86 2 583 650
47. Corzo C. A., Cotter M. J., Cheng P., Cheng F., Kusmartsev S., Sotomayor E., Padhya T., McCaffrey T. V., McCaffrey J. C., Gabrilovich D. I., Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells Journal of Immunology 2009 182 9 5693 5701
48. Nagaraj S., Gupta K., Pisarev V., Kinarsky L., Sherman S., Kang L., Herber D. L., Schneck J., Gabrilovich D. I., Altered recognition of antigen is a mechanism of CD8 + T cell tolerance in cancer Nature Medicine 2007 13 7 828 835 (Pubitemid 47038194)
49. Yang R., Cai Z., Zhang Y., Yutzy W. H., Roby K. F., Roden R. B. S., CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1 + CD11b + myeloid cells Cancer Research 2006 66 13 6807 6815 (Pubitemid 44085641)
50. Serafini P., Mgebroff S., Noonan K., Borrello I., Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells Cancer Research 2008 68 13 5439 5449
51. Karp S. J., Mannon R. B., What's new, what's hot in solid organ transplantation? Summary of the American Transplant Congress 2011 American Journal of Transplantation 2011 11 11 2308 2316
52. Gabrilovich D. I., Velders M. P., Sotomayor E. M., Kast W. M., Mechanism of immune dysfunction in cancer mediated by immature Gr-1 + myeloid cells Journal of Immunology 2001 166 9 5398 5406 (Pubitemid 32374159)
53. Kusmartsev S., Nagaraj S., Gabrilovich D. I., Tumor-associated CD8 + T cell tolerance induced by bone marrow-derived immature myeloid cells Journal of Immunology 2005 175 7 4583 4592 (Pubitemid 41361997)
54. Ostrand-Rosenberg S., Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity Cancer Immunology, Immunotherapy 2010 59 10 1593 1600
55. Kim Y.-J., Park S.-J., Broxmeyer H. E., Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8 + T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction Journal of Immunology 2011 187 5 2291 2301
56. Sinha P., Clements V. K., Bunt S. K., Albelda S. M., Ostrand-Rosenberg S., Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response Journal of Immunology 2007 179 2 977 983
57. Delano M. J., Scumpia P. O., Weinstein J. S., Coco D., Nagaraj S., Kelly-Scumpia K. M., O'Malley K. A., Wynn J. L., Antonenko S., Al-Quran S. Z., Swan R., Chung C. S., Atkinson M. A., Ramphal R., Gabrilovich D. I., Reeves W. H., Ayala A., Phillips J., LaFace D., Heyworth P. G., Clare-Salzler M., Moldawer L. L., MyD88-dependent expansion of an immature GR-1 + CD11b + population induces T cell suppression and Th2 polarization in sepsis Journal of Experimental Medicine 2007 204 6 1463 1474 (Pubitemid 46919883)